artigo Esteato-hepatite.p65 - Sociedade de Gastroenterologia do ...

HESTEATO-HEPATITE NÃO-ALCOÓLICA
29. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history
of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to
hepatocellular carcinoma. Gastroenterology 2002;123:134-40.
30. Harrison SA & Neuschwander-Tetri BA. Pharmacologic management
of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:715-28.
31. Weigle DS. Pharmacological therapy of obesity: past, present, and
future. J Clin Endocrinol Metab 2003; 88:2.462-69.
32. Zelber-Sagi S, Kessler A, Brazowsky E et al. Randomized placebocontrolled
trial of orlistat for the treatment of patients with non
alcoholic fatty liver disease (NAFLD). Hepatology 2004;40:237A.
33. Dixon JB, Bhathal PS, Hughes NR, O’Brien PE. Nonalcoholic fatty
liver disease: Improvement in liver histological analysis with weight
loss. Hepatology 2004; 39:1.647-1.654.
34. Ludwig J, Laurin J, Lindor KD et al. Ursodeoxycholic acid or clofibrate
in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Hepatology 1996;23:1.464-1.467.
35. Lindor KD, Kowdley KV, Heathcote EJ et al. Ursodeoxycholic acid for
treatment of nonalcoholic steatohepatitis: Results of a randomized
trial. Hepatology 2004;39:770-778.
36. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E
and vitamin C treatment improves fibrosis in patients with nonalcoholic
steatohepatitis. Am J Gastroenterol 2003;98:2.485-2.490.
37. Mattos AA, Zamin IJ, Coral GP, Santos DE, Soares EB, Migon EZ.
Antioxidant vitamin E prevents the development of nonalcoholic
steatohepatitis (NASH) in rats. J Hepatol 2004;40:174A.
38. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ,
Guallar E. Meta-Analysis: High-Dosage vitamin E supplementation
may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
39. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon
BR. Improved nonalcoholic steatohepatitis after 48 weeks of
treatment with the PPAR- ligand rosiglitazone. Hepatology
2003;38:1.008-1.017.
40. Promrat K, Lutchman G, Uwaifo GI et al. A pilot study of pioglitazone
treatment for nonalcoholic steatohepatitis. Hepatology
2004;39:188-196.
41. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N.
Metformin in non-alcoholic steatohepatitis. Lancet 2001;358:893-4.
42. Yokohama S, Yoneda M, Haneda M et al. Therapeutic efficacy of an
angiotensin II receptor antagonist in patients with nonalcoholic
steatohepatitis. Hepatology 2004;40:1.222-5.
43. Kim WR, Poterucha JJ, Porayko MK et al. Recurrence of nonalcoholic
steatohepatitis following liver transplantation. Transplantation
1996;62:1.802-1.805.
Endereço para correspondência
Dr. Angelo Alves de Mattos
Rua Professor Anna Dias, 55 / 1.103 - Centro
90020-090 – Porto Alegre - RS
JBG, J. bras. gastroenterol., Rio de Janeiro, v.5, n.4, p.160-165, out./dez. 2005 165